NYSE · ITT
ITT Inc.
$202.56+$6.56 (+3.35%)
ITT Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.05% below the high.
Loading market information…
NYSE · ENOV · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Enovis Corporation’s quoted price sits in the lower half of its reported 52-week range, 29.62% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Enovis Corporation’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of $0.77. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Enovis Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 8, 2025 | $0.81+9.46% vs estimate | $558.83M+1.41% vs estimate |
|---|
| Q4 2024 | Feb 26, 2025 | $0.98+6.52% vs estimate | $560.98M+2.41% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | $0.73+15.87% vs estimate | $505.22M-9.03% vs estimate |
|---|
THE ANALYST VIEW
15 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 6 contributors · Median target $35.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$202.56+$6.56 (+3.35%)
ITT Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.05% below the high.
$239.33+$0.79 (+0.33%)
IDEX Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.83% below the high.
$350.89+$8.02 (+2.34%)
Watts Water Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.06% below the high.
$85.29+$0.23 (+0.27%)
Donaldson Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.42% below the high.
$284.44+$1.40 (+0.49%)
EnPro Industries, Inc.’s quoted price sits in the lower half of its reported 52-week range, 27.15% below the high.
$117.59+$3.55 (+3.11%)
The Middleby Corporation’s quoted price sits in the lower half of its reported 52-week range, 20.84% below the high.
$96.74+$0.09 (+0.09%)
Franklin Electric Co., Inc.’s quoted price sits in the lower half of its reported 52-week range, 16.47% below the high.
$271.33+$5.53 (+2.08%)
Kadant Inc.’s quoted price sits in the lower half of its reported 52-week range, 23.37% below the high.
